Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic gut microorganisms are bacteria, viruses, fungi, and protozoa that cause infectious diseases or inflammatory disorders in the gastrointestinal tract. Common examples include Escherichia coli (certain pathogenic strains), Clostridium difficile, Salmonella spp., Campylobacter jejuni, norovirus, and Candida albicans. These organisms can infect the gut, leading to symptoms ranging from mild gastrointestinal upset to severe, life-threatening illness. Pathogenicity arises from abilities such as toxin production, tissue invasion, and immune evasion. Alterations in the gut microbiota ("dysbiosis") can promote overgrowth of these pathogens, especially following antibiotic use. Therapeutic strategies target the microorganism itself, usually via antimicrobial drugs or modulation of the gut ecology.
Inhibition of cell wall synthesis (antibiotics), Inhibition of protein or nucleic acid synthesis (antibiotics, antivirals), Disruption of pathogen cell membranes (antifungals), Immunomodulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic gut microorganisms.